FDA DTC Promotion Crackdown Continues with Seven Warning Letters

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FDA DTC Promotion Crackdown Continues With Seven Warning Letters

J.W. Schomisch

September 26, 2025 at 04:54 PM EST

The FDA’s surge of enforcement letters regarding direct-to-consumer (DTC) drug promotions has included seven Warning Letters issued on Sept. 9 and signed by Center for Drug Evaluation and Research Director Dr. George Tidmarsh. Both Novo Nordisk and Eli Lilly received Warning Letters over the “Oprah Special: Shame, Blame and Weight Loss Revolution,” which the agency viewed as ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FDA DTC Promotion Crackdown Continues With Seven Warning Letters

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT